-
Nile Red for Lipid Droplet Imaging
2026-08-20
Nile Red combines red membrane-and-droplet fluorescence with greener, more lipid-droplet-selective imaging for flexible intracellular lipid analysis. This workflow shows how to translate that spectral advantage into reproducible lipid metabolism research, including exploratory studies of laryngeal cancer biology.
-
Puromycin Aminonucleoside for Podocyte Injury
2026-08-20
Puromycin aminonucleoside is the aminonucleoside moiety of puromycin and a nephrotoxic reagent for experimental podocyte injury. It reproducibly produces proteinuria and glomerular pathology in animal models, while transporter-dependent cytotoxicity and solution-handling properties define important experimental boundaries.
-
Protease Inhibitor Cocktail for Rice Stress Assays
2026-08-19
Learn how to use an EDTA-free Protease Inhibitor Cocktail to preserve stress-responsive rice proteins for Western blotting, co-immunoprecipitation, and kinase assays. The workflow connects OsCDPK24/28–OsHSFA4d phosphorylation biology with practical extraction, assay selection, and troubleshooting decisions.
-
Light, Brassinolide, and Arabidopsis Root Growth
2026-08-19
Peng and Zhai show that light and brassinosteroids regulate Arabidopsis seedling root elongation through largely separable effects, challenging the assumption that light-dependent root growth is simply mediated by endogenous brassinosteroid status. Their genotype-by-environment and pharmacological design also reveals that brassinazole responses are strongly context dependent and may include toxicity unrelated to brassinosteroid depletion.
-
AO/PI Staining Solution for Cell Viability
2026-08-18
AO/PI Staining Solution enables rapid live/dead cell discrimination in samples where debris, clumping, or red blood cell interference can compromise conventional counts. This workflow-focused guide applies dual fluorescent DNA dyes to podocyte inflammation and apoptosis models while providing practical controls, timing, and troubleshooting guidance.
-
Dextromethorphan Hydrobromide Neuroprotection Workflows
2026-08-18
Build reproducible excitotoxicity assays with Dextromethorphan hydrobromide, an NMDA receptor antagonist suited to neuronal viability, calcium-flux, electrophysiology, and ischemia-style workflows. This guide connects concentration design, orthogonal readouts, formulation control, and troubleshooting without confusing neuroprotection findings with evidence from unrelated disease models.
-
Hexa His Tag Peptide: Translational Precision
2026-08-17
A mechanistic and strategic guide to using Hexa His tag peptide for cleaner His-tagged protein immunoprecipitation, purification, and interaction analysis.
-
Puromycin Aminonucleoside: From Injury to Assay Design
2026-08-17
Puromycin aminonucleoside is a powerful nephrotoxic reagent for linking podocyte structure to proteinuria and glomerular pathology. This article presents an assay-design framework that combines renal phenotyping with carefully bounded insights from coordinated DNA and RNA methylation research.
-
Lisinopril Dihydrate: Research Workflow Guide
2026-08-16
Lisinopril dihydrate provides a water-compatible, nanomolar ACE inhibition tool for modeling renin–angiotensin signaling across cardiovascular and renal experiments. This guide translates its biochemical profile into practical dose-response workflows, disease-model readouts, selectivity controls, and troubleshooting decisions.
-
G007-LK: Tankyrase 1/2 Inhibitor Workflow
2026-08-15
G007-LK provides a practical way to connect tankyrase activity with AXIN stabilization, β-catenin turnover, and Wnt pathway output in cancer models. This workflow-focused guide covers APC-mutant colorectal systems, Hippo/YAP-linked hepatocellular carcinoma assays, dosing strategy, and common troubleshooting points.
-
Maraviroc (A8311) for Reliable CCR5 Assays
2026-08-14
Learn how Maraviroc (SKU A8311) can improve CCR5-focused viability, proliferation, and viral-entry workflows through careful solvent control, assay selection, and data interpretation. This scenario-based guide connects HIV-1 entry inhibition with emerging inflammatory applications while distinguishing established evidence from practical laboratory recommendations.
-
Dimetridazole: Mechanism, Fate, and Assay Design
2026-08-14
Dimetridazole, also known as 1,2-Dimethyl-5-nitroimidazole, is more than an antimicrobial assay reagent. This evidence-led guide connects its microbial effects with hydroxyl-radical degradation, transformation-product toxicity, redox sensing, and better decisions in bacterial culture assay and infection model research.
-
Sodium Picosulfate in Gut–Brain Assays
2026-08-13
Sodium Picosulfate offers a controllable chemical perturbation for epithelial, hepatic, stool-output, and gut–liver–brain experiments. This guide translates its formulation data and recent neuroinflammation-imaging evidence into practical workflows, controls, and troubleshooting strategies without confusing exploratory research with clinical treatment.
-
In Vitro Drug Responses: Viability, Arrest, and Death
2026-08-13
Hannah R. Schwartz’s 2022 dissertation separates relative viability from fractional viability to clarify whether an anticancer treatment primarily stops proliferation, induces cell death, or does both. Its central practical contribution is a more discriminating framework for interpreting drug-response assays, especially when growth inhibition and killing occur with different magnitudes and timing.
-
Dovitinib (TKI-258): RTK Signaling in Cancer Research
2026-08-12
Dovitinib (TKI-258) is a multitargeted receptor tyrosine kinase inhibitor with low-nanomolar activity against FLT3, c-Kit, FGFR, VEGFR, and PDGFR family members. Its reported suppression of ERK and STAT signaling supports apoptosis induction in cancer cells, while the supplied prostate cancer circRNA study provides a separate, hypothesis-generating framework rather than direct Dovitinib evidence.